Infusion of chemotherapy has long been a profit center for medical oncologists. Under the current system, oncologists purchase cancer drugs at one price, then bill insurers at a higher price after they administer the drugs. However, the profits available to oncologists from this practice have been under serious pressure from the pharmaceutical industry and insurers. Pharmaceutical companies have rapidly increased drug prices while insurers, including the Medicare program, have systematically decreased the reimbursement they provide above the cost of the drug. Even though rising drug prices mean, in general, larger absolute profits to oncologists when they administer more expensive drugs (because the amount of profit is proportional to the purchase price of the drug), the decline in profit margins has made running oncology practices more financially challenging. Increases in drug prices mean increasing costs of inventory, and the resulting lower margins mean less financial flexibility when patients or insurers do not pay their bills on time or in total.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.